A low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients

[1]  M. Shlipak,et al.  Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. , 2013, Journal of the American Society of Nephrology : JASN.

[2]  M. Budoff,et al.  Fibroblast growth factor 23 is not associated with and does not induce arterial calcification , 2013, Kidney international.

[3]  M. Kuro-o,et al.  Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease , 2012, BMC Nephrology.

[4]  W. Richards,et al.  FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. , 2012, The Journal of clinical investigation.

[5]  M. Kuro-o.  Klotho in health and disease , 2012, Current opinion in nephrology and hypertension.

[6]  Z. Massy,et al.  FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages , 2012, Osteoporosis International.

[7]  L. Hsiao,et al.  Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23 , 2012, Circulation.

[8]  A. Go,et al.  FGF23 induces left ventricular hypertrophy. , 2011, The Journal of clinical investigation.

[9]  B. Coll,et al.  Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[10]  B. Coll,et al.  Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  E. Farrow,et al.  Recent advances in renal phosphate handling , 2010, Nature Reviews Nephrology.

[12]  L. Lind,et al.  Relationship between circulating FGF23 and total body atherosclerosis in the community. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  C. Chazot,et al.  High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  K. Amann.  Media calcification and intima calcification are distinct entities in chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[15]  S. Moe,et al.  Improving global outcomes in mineral and bone disorders. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[16]  G. London,et al.  Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. , 2008, Journal of the American Society of Nephrology : JASN.

[17]  K. Pointon,et al.  Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  M. Rué,et al.  Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  P. Raggi,et al.  Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. , 2006, Kidney international.

[20]  M. Inaba,et al.  Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients , 2006, Osteoporosis International.

[21]  P. Raggi,et al.  Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. , 2005, Kidney international.

[22]  M. Wolf,et al.  Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[23]  V. Andreucci,et al.  Coronary artery calcification in patients with CRF not undergoing dialysis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  C. Wagner,et al.  Kidney-specific inactivation of the megalin gene impairs trafficking of renal inorganic sodium phosphate cotransporter (NaPi-IIa). , 2004, Journal of the American Society of Nephrology : JASN.

[25]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  G. Eknoyan,et al.  Bone metabolism and disease in chronic kidney disease , 2003 .

[27]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  M. Budoff,et al.  Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease. , 2003, Kidney international.

[29]  P. Raggi,et al.  Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? , 2002, Journal of the American College of Cardiology.

[30]  J. Blacher,et al.  Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease , 2001, Hypertension.

[31]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[32]  D. Kiel,et al.  New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. , 1997, Atherosclerosis.

[33]  J. J. Smith,et al.  Estrogen inhibits the response-to-injury in a mouse carotid artery model. , 1995, The Journal of clinical investigation.

[34]  L. Ibels,et al.  Arterial calcification and pathology in uremic patients undergoing dialysis. , 1979, The American journal of medicine.

[35]  W. van Biesen,et al.  Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[36]  A. Torres,et al.  Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  W. Mitch,et al.  A method for estimating nitrogen intake of patients with chronic renal failure. , 1985, Kidney international.

[38]  Y. Caliskan,et al.  Fibroblast Growth Factor-23 (fgf-23) Is Independently Correlated to Aortic Calcification in Haemodialysis Patients Department of Endocrinology and Association of Fgf-23 with Aortic Calcification 2679 , 2022 .